CHIEF EXECUTIVE OFFICER

Yen-Ming Hsu

Yen-Ming Hsu is a co-founder of AB Biosciences. Prior to  AB Biosciences, Yen-Ming was leading the protein engineering group in the Research Department of Biogen.  An accomplished protein biochemist, Yen-Ming has designed more than 200 recombinant proteins, published over 60 peer-reviewed articles, authored 42 granted patents, and successfully out-licensed the recombinant IVIG program to Shire, now Takeda. His most recent effort focuses on AI-based engineering of protein biologics blocking disease-causing pathogenic pathways.